Seeking Alpha

NPS Pharmaceuticals (NPSP) terminates and replaces a prior collaborative research agreement with...

NPS Pharmaceuticals (NPSP) terminates and replaces a prior collaborative research agreement with GlaxoSmithKline (GSK) dating back to 1993. The new agreement will assign two new compounds for study and expand the company's field of research on other drugs. NPSP +7.9%, [[GSK] -0.9% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs